Imunon, Inc.IMNNEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Imunon, Inc. is a clinical-stage biotechnology company specializing in the development of innovative immunotherapies and nucleic acid-based therapeutics. Its core product candidates target multiple solid tumor types and infectious diseases, serving global patient populations through partnerships with healthcare and research institutions across North America, Europe and the Asia-Pacific.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| NOS. OF ABOVE PERSONS | 9.90% | 1.1M | — | 2024-11-14 |
| CVI Investments, Inc. | 4.90% | 761.6K | ▼ -3.60pp | 2024-11-14 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.